Company Search:
Advanced Search
Sponsored Links
Oryzon Genomics Sa Company Snapshot
Oryzon Genomics Sa operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oryzon Genomics Sa with three other miscellaneous service companies in Europe: Silence Therapeutics Plc of the United Kingdom (2017 sales of £16,000.00 [US$21,108.16 ] ), Immunovia AB (publ) of Sweden (148,963.00 Swedish Kronor [US$15,860.09 ] ), and Nanogroup SA which is based in Poland (40,798.00 Polish New Zlotys [US$10,602.58 ] ).

Sales Analysis. Sales fell dramatically in 2017: During the year ended December of 2017, sales at Oryzon Genomics Sa were 16,764.00 Euro (US$18.65 thousand). This is a sharp decrease of 97.7% versus 2016, when the company's sales were 735,312.00 Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oryzon Genomics Sa
  Stock Performance Chart for Oryzon Genomics Sa
  Stock Data: Recent Stock Performance:
  Current Price (12/13/2019): 3.10
(Figures in Euro)
1 Week 3.3%   13 Weeks 13.1%  
4 Weeks 12.3%   52 Weeks 21.1%  
Oryzon Genomics Sa Key Data:
  Ticker: ORY Country: Spain
  Exchanges: MAD Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 16,764
(Year Ending Jan 2018).
Employees: 40
  Currency: Euro Market Cap: 120,347,850
  Fiscal Yr Ends: December Shares Outstanding: 38,821,887
  Share Type: Accion Closely Held Shares: 10,573,263
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.